GENETIC RISK FACTORS AS DETERMINANTS OF THE OUTCOME OF CLINICAL TRIALS IN ALZ

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是确定某些形式的血液蛋白(载脂蛋白E)是否与阿尔茨海默病有关。如果研究人员能够识别出一组具有特定载脂蛋白E蛋白的患者，他们或许就能更多地了解疾病的原因，最终可能会找到治愈的方法。这是一次对参与者进行抽血以确定他们的载脂蛋白E状态。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to determine whether certain forms of blood protein (Apolipoprotein E) are associated with Alzheimer's disease. If the investigators are able to identify a group of patients with the specific Apolipoprotein E protein, they may be able to learn more about the cause of the disease, which could eventually lead to a cure. This is a one time blood draw on participating subjects to determine their Apolipoprotein E status.